SG11202103025PA - Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells - Google Patents

Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells

Info

Publication number
SG11202103025PA
SG11202103025PA SG11202103025PA SG11202103025PA SG11202103025PA SG 11202103025P A SG11202103025P A SG 11202103025PA SG 11202103025P A SG11202103025P A SG 11202103025PA SG 11202103025P A SG11202103025P A SG 11202103025PA SG 11202103025P A SG11202103025P A SG 11202103025PA
Authority
SG
Singapore
Prior art keywords
delta
compositions
expansion
cells
methods
Prior art date
Application number
SG11202103025PA
Inventor
Richard D Lopez
Original Assignee
Phosphogam Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phosphogam Inc filed Critical Phosphogam Inc
Publication of SG11202103025PA publication Critical patent/SG11202103025PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
SG11202103025PA 2018-09-27 2019-09-26 Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells SG11202103025PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862737378P 2018-09-27 2018-09-27
PCT/IB2019/058188 WO2020065584A1 (en) 2018-09-27 2019-09-26 Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells

Publications (1)

Publication Number Publication Date
SG11202103025PA true SG11202103025PA (en) 2021-04-29

Family

ID=68211140

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103025PA SG11202103025PA (en) 2018-09-27 2019-09-26 Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells

Country Status (9)

Country Link
US (1) US20210338728A1 (en)
EP (1) EP3856206A1 (en)
JP (1) JP2022513328A (en)
KR (1) KR20210069665A (en)
CN (1) CN112930187A (en)
AU (1) AU2019349956A1 (en)
CA (1) CA3114292A1 (en)
SG (1) SG11202103025PA (en)
WO (1) WO2020065584A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102648375B1 (en) 2020-10-20 2024-03-14 강승찬 Preparaion of plant fermentation product using plant fermented liquid
WO2022214887A1 (en) 2021-04-08 2022-10-13 Phosphogam, Llc Methods and compositions for enhancing the cytotoxicity of gamma/delta-t cells
WO2022221439A1 (en) * 2021-04-14 2022-10-20 The Trustees Of The University Of Pennsylvania Methods to determine treatment efficacy with gamma-delta t cells
CN114645022B (en) * 2022-05-13 2022-09-02 首都医科大学宣武医院 CD 5-targeted CAR-gamma delta T cell and preparation method and application thereof
CN115678846B (en) * 2022-09-01 2023-06-16 广东龄值生物科技有限公司 Tumor specific gamma delta T cell and preparation method thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
AU610083B2 (en) 1986-08-18 1991-05-16 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5756096A (en) 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
DE614989T1 (en) 1993-02-17 1995-09-28 Morphosys Proteinoptimierung Method for in vivo selection of ligand binding proteins.
CA2323080A1 (en) 1998-03-12 1999-09-16 Emory University Methods and compositions for the selective expansion of gamma/delta t-cells
FR2782721B1 (en) 1998-09-01 2000-11-03 Inst Nat Sante Rech Med NOVEL PHOSPHOHALOHYDRIN COMPOUNDS, MANUFACTURING METHOD AND APPLICATIONS
US7399756B2 (en) 2001-07-20 2008-07-15 Bioagency Ag Organo-phosphorous compounds for activating gamma/delta T cells
FR2833266B1 (en) 2001-12-11 2004-10-22 Mayoly Spindler Lab NOVEL PHOSPHONATE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE AS MODULATORS OF THE ACTIVITY OF TGAMMA9 DELTA2 LYMPHOCYTES
FR2836483B1 (en) 2002-02-22 2006-09-15 Innate Pharma METHODS FOR PRODUCING GAMMA DELTA T LYMPHOCYTES
EP1878440A1 (en) * 2006-07-13 2008-01-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
CN102137925B (en) 2008-07-01 2014-12-10 迈世耐特股份公司 Method for simultaneous induction of CTL and [gamma][delta]t cell
US8735624B2 (en) 2008-09-10 2014-05-27 Innate Pharma Polymorphic form of CHDMAPP, method of preparation thereof, and pharmaceutical composition comprising same
US20150353643A1 (en) 2013-09-24 2015-12-10 Universite De La Mediterranee - Aix-Marseille Ii Anti-cd277 antibodies and uses thereof
WO2014072446A1 (en) * 2012-11-08 2014-05-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for inducing il-2-free proliferation of gamma delta t cells
CN107075480A (en) * 2014-07-09 2017-08-18 Tc生物制药有限公司 Gamma delta T cells and application thereof
GB201421716D0 (en) * 2014-12-05 2015-01-21 King S College London Cell expansion procedure
IL257678B2 (en) * 2015-08-25 2024-04-01 Uab Res Found Methods for stem cell transplantation

Also Published As

Publication number Publication date
KR20210069665A (en) 2021-06-11
US20210338728A1 (en) 2021-11-04
WO2020065584A1 (en) 2020-04-02
CN112930187A (en) 2021-06-08
EP3856206A1 (en) 2021-08-04
JP2022513328A (en) 2022-02-07
CA3114292A1 (en) 2020-04-02
AU2019349956A1 (en) 2021-04-29

Similar Documents

Publication Publication Date Title
IL282735A (en) Compositions and methods for t cell engineering
SG11202103025PA (en) Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells
IL277079A (en) Cartyrin compositions and methods for use
GB201707048D0 (en) Expansion of gamma delta cells, compositions, and methods of use thereof
IL268058A (en) Compositions and methods for the depletion of cd137plus cells
IL263743A (en) Compositions and methods for the depletion of cells
SG10202100726XA (en) Compositions and methods for the depletion of cd117+cells
SG11202003280SA (en) Compositions and methods for the depletion of cd117+ cells
EP3694533A4 (en) Methods and compositions for expansion of cell population
IL291622A (en) Compositions comprising regulatory t cells and methods of making and using the same
HK1252778A1 (en) Cell expansion methods and therapeutic compositions
IL281015A (en) Methods and compositions for the modification of plants
ZA202100780B (en) Bismuth-thiol compositions and methods of use
IL276135A (en) Compositions and methods of use
IL274291A (en) Compounds and use thereof in the expansion of stem cells and/or progenitor cells
IL274817A (en) Compositions and methods for the depletion of cd2(plus) cells
SG11202110879PA (en) Compositions and methods for preparing t cell compositions and uses thereof
SG11202004294XA (en) Compositions and methods for the depletion of cd5+ cells
GB202208953D0 (en) Therapeutic cell compositions and methods for manufacture and uses thereof
IL278201A (en) Methods and compositions of cytotoxic t cell depletion
IL290297A (en) Modified cytotoxic t cells and methods of use thereof
IL282160A (en) Compositions and methods for transfecting cells
IL282533A (en) Oligosaccharide compositions and methods of use thereof
GB202014449D0 (en) Compositions and methods of cell attachment
IL287010A (en) Compositions and methods for the cryopreservation of immune cells